These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cloning, Purification, and Characterization of Recombinant Human Extracellular Superoxide Dismutase in SF9 Insect Cells. Shrestha P; Yun JH; Kim WT; Kim TY; Lee W Mol Cells; 2016 Mar; 39(3):242-9. PubMed ID: 26912083 [TBL] [Abstract][Full Text] [Related]
43. Markers of Oxidative Stress during Diabetes Mellitus. Tiwari BK; Pandey KB; Abidi AB; Rizvi SI J Biomark; 2013; 2013():378790. PubMed ID: 26317014 [TBL] [Abstract][Full Text] [Related]
44. Regulation of lung oxidative damage by endogenous superoxide dismutase in sepsis. Constantino L; Gonçalves RC; Giombelli VR; Tomasi CD; Vuolo F; Kist LW; de Oliveira GM; Pasquali MA; Bogo MR; Mauad T; Horn A; Melo KV; Fernandes C; Moreira JC; Ritter C; Dal-Pizzol F Intensive Care Med Exp; 2014 Dec; 2(1):17. PubMed ID: 26266917 [TBL] [Abstract][Full Text] [Related]
45. Regulation of Oxidative Stress in Pulmonary Artery Endothelium. Modulation of Extracellular Superoxide Dismutase and NOX4 Expression Using Histone Deacetylase Class I Inhibitors. Zelko IN; Folz RJ Am J Respir Cell Mol Biol; 2015 Oct; 53(4):513-24. PubMed ID: 25749103 [TBL] [Abstract][Full Text] [Related]
46. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. Nozik-Grayck E; Woods C; Taylor JM; Benninger RK; Johnson RD; Villegas LR; Stenmark KR; Harrison DG; Majka SM; Irwin D; Farrow KN Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(11):L868-76. PubMed ID: 25326578 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of extracellular superoxide dismutase protects against brain injury induced by chronic hypoxia. Zaghloul N; Patel H; Codipilly C; Marambaud P; Dewey S; Frattini S; Huerta PT; Nasim M; Miller EJ; Ahmed M PLoS One; 2014; 9(9):e108168. PubMed ID: 25268361 [TBL] [Abstract][Full Text] [Related]
48. The role of oxidative stress and inflammation in cardiovascular aging. Wu J; Xia S; Kalionis B; Wan W; Sun T Biomed Res Int; 2014; 2014():615312. PubMed ID: 25143940 [TBL] [Abstract][Full Text] [Related]
49. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat diet-derived endothelial dysfunction. Gil-Ortega M; Condezo-Hoyos L; García-Prieto CF; Arribas SM; González MC; Aranguez I; Ruiz-Gayo M; Somoza B; Fernández-Alfonso MS PLoS One; 2014; 9(4):e95312. PubMed ID: 24760053 [TBL] [Abstract][Full Text] [Related]
50. Muscle contraction increases interstitial nitric oxide as predicted by a new model of local blood flow regulation. Golub AS; Song BK; Pittman RN J Physiol; 2014 Mar; 592(6):1225-35. PubMed ID: 24445318 [TBL] [Abstract][Full Text] [Related]
51. Expression of extracellular superoxide dismutase protein in diabetes. Kim CH Arch Plast Surg; 2013 Sep; 40(5):517-21. PubMed ID: 24086803 [TBL] [Abstract][Full Text] [Related]
52. Ovariectomy increases the participation of hyperpolarizing mechanisms in the relaxation of rat aorta. Sagredo A; del Campo L; Martorell A; Navarro R; Martín MC; Blanco-Rivero J; Ferrer M PLoS One; 2013; 8(9):e73474. PubMed ID: 24058477 [TBL] [Abstract][Full Text] [Related]
53. Copper transporter ATP7A protects against endothelial dysfunction in type 1 diabetic mice by regulating extracellular superoxide dismutase. Sudhahar V; Urao N; Oshikawa J; McKinney RD; Llanos RM; Mercer JF; Ushio-Fukai M; Fukai T Diabetes; 2013 Nov; 62(11):3839-50. PubMed ID: 23884884 [TBL] [Abstract][Full Text] [Related]
55. Cardiological biopharmaceuticals in the conception of drug targeting delivery: practical results and research perspectives. Maksimenko AV Acta Naturae; 2012 Jul; 4(3):72-81. PubMed ID: 23150805 [TBL] [Abstract][Full Text] [Related]
56. Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Obal D; Dai S; Keith R; Dimova N; Kingery J; Zheng YT; Zweier J; Velayutham M; Prabhu SD; Li Q; Conklin D; Yang D; Bhatnagar A; Bolli R; Rokosh G Basic Res Cardiol; 2012 Nov; 107(6):305. PubMed ID: 23099819 [TBL] [Abstract][Full Text] [Related]
58. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Maksimenko AV; Vavaev AV Heart Int; 2012 Feb; 7(1):e3. PubMed ID: 22690296 [TBL] [Abstract][Full Text] [Related]
59. Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase. Chung BH; Kim S; Kim JD; Lee JJ; Baek YY; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM Exp Mol Med; 2012 Mar; 44(3):191-201. PubMed ID: 22170035 [TBL] [Abstract][Full Text] [Related]
60. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Fukai T; Ushio-Fukai M Antioxid Redox Signal; 2011 Sep; 15(6):1583-606. PubMed ID: 21473702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]